Compare Old Dominion Freight Line Inc (ODFL) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Old Dominion Freight Line Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Old Dominion Freight Line Inc trades at $181.97 (market cap $37.68B), while State Street SPDR S&P Biotech ETF trades at $153.75 (market cap $10.11B). The key difference: Old Dominion Freight Line Inc is far larger — about 3.7× State Street SPDR S&P Biotech ETF's market cap, and Old Dominion Freight Line Inc pays a 0.64% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Old Dominion Freight Line Inc for 76 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| ODFL | XBI | |
|---|---|---|
Market Cap | $37.68B | $10.11B |
Volume | 1,550,104 | 12,903,266 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $248.73 | $169.55 |
52-Week Low | $126.29 | $104.99 |
Typical Hold Time | 76 Days | 38 Days |
Enterprise Value | $37.42B | — |
Dividend Yield | 0.64% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ODFL trades at $181.65, up 3.44% today, with strong recent earnings beats and a 4.9% general rate increase effective October 5, 2026, to counter rising costs. The stock shows robust fundamentals with a 19.44% net income margin and 24.82% ROE, though valuation ratios like P/E of 34.95 are elevated. Technical indicators are bearish overall, with support at $180 and resistance at $183, while analyst consensus is mixed with a $230.93 price target.
Outlook: ODFL's consistent earnings outperformance and strategic rate hikes support growth, but high valuation and bearish technical signals pose near-term risks. Investors should weigh solid profitability against potential volatility from freight market fluctuations and competitive pressures.
XBI trades at $149.29, down 0.63% on the day, with technical indicators showing a bearish bias despite an oversold RSI reading. The ETF faces mixed sentiment with 100% hold ratings from analysts but positive news flow around biotech catalysts. Recent articles highlight XBI's biotech focus versus broader healthcare ETFs, with expense ratio comparisons and volatility considerations.
The outlook remains cautious due to technical weakness and high volatility, though sector-specific catalysts like cancer vaccine developments and M&A activity provide potential upside. Key risks include sector volatility, regulatory uncertainty, and competitive ETF offerings with lower fees.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Old Dominion Freight Line Inc
Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.
Read more on ODFL →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
